Stingray Therapeutics
Houston, Texas, United Statesstingraytx.com
Stingray Therapeutics is developing Vizenpistat (SR-8541A), the world's most advanced ENPP1 inhibitor, in active clinical trials with a strong safety profile…
Founders and contacts
- FoundersBeing confirmed, locked
- Founder emailsBeing confirmed, locked
- LinkedInCompany page, locked
- Office addressStreet address, locked
Explore
More startups in Houston
Is Stingray Therapeutics yours? Feature it on the map for $49 a month, in front of everyone who opens it.
Are you a founder of Stingray Therapeutics and want your details removed? Write to us and we remove them within 72 hours.